Quick Asked: Pliant Therapeutics Contact Us?

Last update: 03 May, 2024 189 Views

Who is pliant therapeutics? Pliant Therapeutics is a clinical stage biopharmaceutical company focused on discovering and developing novel therapeutics that seek to halt progression of fibrotic diseases — ultimately preserving organ function.

What is pliant therapeutics quality score? Pliant Therapeutics, Inc. was founded in 2015 and is based in South San Francisco, California. Pliant Therapeutics, Inc.’s ISS Governance QualityScore as of July 1, 2021 is 8.

What is plupliants pln 1474? Pliant’s second clinical stage product candidate, PLN-1474, is designed to be a small molecule selective inhibitor of αvβ1, targeting liver fibrosis associated with nonalcoholic steatohepatitis (NASH) and is partnered with Novartis. PLN-1474 is currently in Phase 1 testing.

Whats in pliants pipeline? Pliant’s broad pipeline includes two clinical stage programs, including the first clinical stage, oral, selective small molecule integrin inhibitor. Pliant's approach has the potential to significantly advance the treatment of fibrosis. We cannot succeed on this journey without you.

Listing Results Pliant Therapeutics Contact Us? Question Answers